Sana Biotechnology, Inc. Common Stock (SANA) is a publicly traded Healthcare sector company. As of August 24, 2026, SANA trades at $3.94 with a market cap of $1.17B and a P/E ratio of -4.06. SANA moved +0.77% today. Year to date, SANA is -3.93%; over the trailing twelve months it is +8.61%. Its 52-week range spans $1.26 to $7.30. Analyst consensus is strong buy with an average price target of $8.00. Rallies surfaces SANA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
5 analysts cover SANA: 0 strong buy, 5 buy, 0 hold, 0 sell, and 0 strong sell. The consensus rating is strong buy. The average price target is $8.00.
| Metric | Value |
|---|---|
| Price | $3.94 |
| Market Cap | $1.17B |
| P/E Ratio | -4.06 |
| EPS | $-0.96 |
| Dividend Yield | 0.00% |
| 52-Week High | $7.30 |
| 52-Week Low | $1.26 |
| Volume | 10.12K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-244.17M |
| Gross Margin | 0.00% |
5 analysts cover SANA: 0 strong buy, 5 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $8.00.